06 Nov 2018 Mauricio Graber took the helm as new Chr. Hansen CEO on June 1, 2018, having previously served as President of the Flavours Division of Givaudan. Chr. Hansen recently reported its Q4 and full financial earnings. The company announced that it had achieved the overall financial targets set at the beginning of the year and raised its ambitions 9-11 percent organic growth for next year. It is the company’s core business of Cultures & Enzymes, which represents 59 percent of their business that performed the strongest, with bioprotection and probiotics forming key pillars here. FoodIngredientsFirst spoke with Mauricio about the current business environment and new opportunities for microbes.
PLEASE SUBMIT YOUR CONTACT DETAILS TO LISTEN PODCAST